Bank Of Montreal Albireo Pharma, Inc. Call Options Transaction History
Bank Of Montreal
- $197 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ALBO
# of Institutions
4Shares Held
865Call Options Held
0Put Options Held
0About ALBIREO PHARMA, INC.
- Ticker ALBO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 19,612,500
- Description
- Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...